Recombinant Protein L Type 1 Protein

SDS-Page: Protein L Type 1 Cys (C-Term) Protein [NBP2-35049]

HPLC: Recombinant Protein L Type 1 Protein [NBP2-35049] - Protein L Type 1 Cys (C-Term) Protein [NBP2-35049]

• Applications: Func, PAGE, Bioactivity
• Format: Carrier-Free
• Concentration: LYOPH

Recombinant Protein L Type 1 Protein Summary

• Description: A single, non-glycosylated biologically active polypeptide chain with a Cys on the C-terminal containing 366 residues of Protein L Type 1 protein. It migrates with an apparent molecular mass of 46kDa in SDS-PAGE.
  
  

  Source: E. coli

  Amino Acid Sequence: KEETPETPET DSEEEVTIKA NLIFANGSTQ TAEFKGTFEK ATSEAYAYAD TLKKDNGEYT VDVADKGYTL NIKFAGKEKT PEEPKEEVTI KANLIYADGK TQTAEFKGTF EEATAEAYRY ADALKKDNGE YTVDVADKGY TLNIKFAGKE KTPEEPKEEV TIKANLIYAD GKTQTAEFKG TFEEATAEAY RYADLLAKEN GKYTVDVADK GYTLNIKFAG KEKTPEEPKE EVTIKANLIY ADGKTQTAEF KGTFAEATAE AYRYADLLAK ENGKYTADLE DGGYTINIRF AGKKVDEKPE EKEQVTIKEN IYFEDGTVQT ATFKGTFAEA TAEAYRYADL LSKEHGKYTA DLEDGGYTIN IRFAGC

• Preparation Method: Novus' biologically active proteins are stringently purified to provide only the safest and most highly effective proteins available. This protein was expressed in E. coli, purified by HPLC, QC tested by SDS-PAGE and Western Blot and validated on appropriate cell lines for bioactivity. All HPLC and bioactivity data is provided for your assurance.
• Details of Functionality: Protein L is a genetically engineered protein containing 5 IgG-binding regions of protein L. Cell wall binding region, cell membrane binding region and albumin binding region have been removed from the recombinant Protein L to ensure the maximum specific IgG binding. Protein L binds to human, mouse, rat and pig IgG.
• Source: E. coli
• Protein/Peptide Type: Recombinant Protein
• Purity: >96%, by HPLC
• Endotoxin Note: Less than 0.1 EU/ug of endotoxin as determined by LAL method.

Applications/Dilutions

• Theoretical MW: 40.6 kDa.
  Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: Lyophilized from solution of 20mM PB (pH 7.0)
• Concentration: LYOPH
• Purity: >96%, by HPLC
• Reconstitution Instructions: Reconstitute with distilled water or saline.

Notes

This lyophilized preparation is stable at 2-8 degrees C, but should be kept at -20 degrees C for long term storage, preferably desiccated. Upon reconstitution, the preparation is most stable at -20 to -80 degrees C, and can be stored for one week at 2-8 degrees C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 degrees C to -80 degrees C. Avoid repeated freeze/thaw cycles.

Background

Protein L contains 5 kappa-binding domain. Protein L has the unique ability to bind through kappa light chain interactions without interfering with the antibody's antigen-binding site. This gives Protein L the ability to bind a wider range of Ig classes and subclasses than other antibody-binding proteins.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.